Key facts
- Notable investors include Finnova Capital, Jintan Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Aeonvital
- ·The full record, as it builds
Funding rounds
No funding rounds for Aeonvital are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aeonvital
Researcher of of tumor immunotherapy and cancer therapeutic vaccines designed to positively improve human health. The company focuses on malignant tumors researches and develops various products related to tumor-infiltrating lymphocytes, natural killer cells, as well as therapeutic cancer vaccines preventive vaccines such as HPV (Human Papillomavirus), providing patients with advanced precision tumor treatment.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2021
- Website
- aeonvital.com/
- Ownership
- Privately Held (backing)
Aeonvital doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aeonvital shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aeonvital in its N-PORT filings yet. We sweep new filings monthly.